Biotech

Selected news for the healthcare topic - Biotech, collected since 10/2017. Recent stories appear in alarabiya.net and FierceBiotech. This healthcare topic shares news with COVID-19, COVID-19 Vaccine, Coronavirus, Pfizer, AstraZeneca and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
5/9/2021 US wants COVID-19 vaccine patent waiver to benefit world, not boost China biotech alarabiya.net US wants COVID-19 vaccine patent waiver to benefit world, not boost China biotech Enable Read mode A URL Copied A model of a coronavirus is displayed next to boxes for COVID-19 vaccines at an exhibit by Chinese pharmaceutical firm Sinopharm in Beijing, Sept. 5, 2020. (AP Photo/Mark Schiefelbein) 09 May ,2021: 04:49 AM GST Updated: 09 May ,2021: 04:54 AM GST URL Copied The Biden administration is ...
5/9/2021 Abingworth raises $582M clinical co-development fund amid rising biotech interest FierceBiotech ... could be amortized over the sales of the product.Abingworth still works with pharma companies, but they are no longer the only game in town. “What has changed quite significantly is the interest from biotechs,” Haines said. “The motivation there is slightly different. Clearly, most biotechs are not profitable, so the earnings per share issue is less critical. But what we're able to do is to significantly reduce the ...
5/9/2021 U.S. Senate committee revised a draft bill to fund AI, quantum, biotech VentureBeat ... most of the money, $95 billion, over five years to invest in basic and advanced research, commercialization, and education and training programs in key technology areas, including artificial intelligence , semiconductors, quantum computing, advanced communications, biotechnology and advanced energy.The measure, sponsored by Senate Majority Leader Chuck Schumer, a Democrat, Republican Senator Todd Young and others, would also authorize another $10 billion to designate at least 10 regional technology hubs and ...
5/9/2021 U.S. wants COVID vaccine patent waiver to benefit world, not boost China biotech MSN ... Enforcing limits on use of the technology could be very difficult, once handed over, some analysts say. Messenger RNA, used in COVID-19 vaccines by leaders Pfizer/BioNTech and Moderna, is a newly developed biotechnology that holds promise for treatments far beyond vaccines. China and Russia have their own vaccines that do not use this biotechnology. "It took Pfizer and Moderna years and years of research to develop these vaccines ...
5/8/2021 Chicago Tribune's No. 2 Investor Says Papers Need Government Aid – Bloomberg Bloomberg Biotech Mogul Behind L.A. Times Says Papers Need Government Aid By May 7, 2021, 2:55 PM EDT Patrick Soon-Shiong says tech giants should pay for articles He’s also No. 2 investor in Tribune, which is weighing bids NantKwest's Soon-Shiong on BioTech and the Future of Newspapers LISTEN TO ARTICLE TweetThe owner of the Los Angeles Times is calling on the government to throw its support behind ...
5/8/2021 Why CureVac, Novavax, Sanofi, GSK and Valneva could soon contribute to the COVID-19 vaccine rollout | Fortune Fortune ... vaccinate—and possibly new mutations that will need addressing.Here’s a rundown of four potentially serious players and what they have to offer.CureVac Who?CureVac is the smallish, two-decade-old German biotech that President Donald Trump reportedly offered $1 billion to exclusively serve the U.S. The political fallout led the European Commission to loan the company €75 million ($90 million), while Germany invested €300 million ...
5/8/2021 Investors Purchase Large Volume of Call Options on SPDR S&P Biotech ETF (NYSEARCA:XBI) - Transcript Daily transcriptdaily.com SPDR S&P Biotech ETF (NYSEARCA:XBI) saw unusually large options trading on Thursday. Stock investors bought 116,626 call options on the company. This represents an increase of 200% compared to the typical volume of 38,875 call options.Shares of NYSEARCA:XBI opened at $127.74 on Friday. The business’s fifty day moving average price is $134.50 and its two-hundred day moving average price is $139.98. SPDR S&P ...
5/8/2021 Stock Traders Buy High Volume of Call Options on SPDR S&P Biotech ETF (NYSEARCA:XBI) - Stock Observer thestockobserver.com SPDR S&P Biotech ETF (NYSEARCA:XBI) saw unusually large options trading on Thursday. Traders purchased 116,626 call options on the stock. This is an increase of 200% compared to the average volume of 38,875 call options.A number of institutional investors and hedge funds have recently made changes to their positions in the business. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in SPDR S&P Biotech ...
5/8/2021 ‘No preparedness planning, no accountability, no action plan’ popularindinews.com ... has anybody been listening to me? Every country has to share the risk with the private sector.If I were doing good preparedness planning I would tell the Serum Institute of India and Bharat Biotech way back in August ‘just keep making vaccines, whether they are approved or not’.There was a very low risk of failure. The government should have asked them to keep making vaccines and given ...
5/8/2021 Xenter, Inc. Appoints Industry Leaders Robert S. Langer, Elazer R. Edelman, David J. Bearss and Mark Stautberg to Board of Directors; Closes $12M Series A mobilevillage.com ... at MIT, Professor of Medicine at Harvard Medical School, Interventional Cardiologist and Senior Attending Physician in the cardiac critical care unit at the Brigham and Women’s Hospital in Boston. David J. Bearss, PhD , biotech industry leader and serial entrepreneur with multiple therapeutic drug company exits and Senior Managing Director, UTAH Therapeutics Accelerator at the University of Utah. Mark Stautberg , a widely recognized senior commercial leader and former SVP of ...
5/8/2021 Patent waiver: Boon or Bane for Mass Vaccination drives? manipalblog.com ... and production, technological advancements have thrown light on reducing the fatal outcomes of viral infection. Despite of achieving success in vaccine development, either it could be from the Serum Institute of India or Bharat Biotech , and it is evident from the reports that the production is not sufficient enough for the unstratified mass vaccination strategy. The Indian biotech giants, who had got the patents and approval from the Government of ...
5/8/2021 Fortress Biotech, Inc. (NASDAQ:FBIO) Given Consensus Rating of “Buy” by Brokerages - Watch List News watchlistnews.com Shares of Fortress Biotech, Inc. (NASDAQ:FBIO) have received a consensus rating of “Buy” from the seven brokerages that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12 month price target among analysts that have covered the stock in the last year is $10.80.FBIO has been the subject ...
5/8/2021 In fight against Covid variants some firms target T cell jabs MSN ... T cells in hopes of producing a jab that would not only provide protection against new virus strains already on the loose, but also variants that don't yet exist. Alexis Peyroles heads up French biotech firm OSE Immunotherapeutics, which is developing a vaccine that targets T cells that has just begun clinical trials. "It could offer several years of protection," he told AFP. Another French firm, Lyon-based Osivax, is ...
5/8/2021 Explained: How does China's Sinopharm COVID-19 vaccine work? slicknewz.com ... March to meet its domestic demand as coronavirus cases started surging towards the end of February.How does this vaccine work?The Sinopharm vaccine is an inactivated coronavirus vaccine, like Covaxin developed by Bharat Biotech India (BBIL) in collaboration with the National Institute of Virology (NIV).Inactivated vaccines take the disease-carrying virus (in this case SARS-CoV-2) and kill it using heat, chemicals or radiation. WHO notes that ...
5/8/2021 Pancreatic Cancer Market 2020 Anticipated CAGR Growth and Impact Analysis by 2026 themarketcorrespondent.com ... PDF of the Pancreatic Cancer Market Report (including TOC, Set of tables and figures, chart): https://www.futuristicreports.com/request-sample/44785 Top Players on this Pancreatic Cancer Market:( AB Science, AbGenomics International, Aphios, Celgene, Aduro Biotech , Novartis, Zeria Pharmaceutica, Halozyme Therapeutics, Ostuka Holdings, F. Hoffmann-La Roche, Rexahn Pharmaceuticas, Momenta Pharmaceuticals, Gilead Sciences, OncoMed Pharmaceuticals, Celsion, Eli Lilly, Merrimack Pharmaceuticals, Pfizer, Oncozyme Pharma )The Pancreatic Cancer Pancreatic Cancer industry indepth analysis ...
5/8/2021 In fight against Covid variants some firms target T cell jabs Yahoo News ... T cells in hopes of producing a jab that would not only provide protection against new virus strains already on the loose, but also variants that don't yet exist.Alexis Peyroles heads up French biotech firm OSE Immunotherapeutics, which is developing a vaccine that targets T cells that has just begun clinical trials."It could offer several years of protection," he told AFP.Another French firm, Lyon-based Osivax, is ...
5/8/2021 Fortress Biotech, Inc. (NASDAQ:FBIO) Given Consensus Recommendation of “Buy” by Brokerages - WKRB News wkrb13.com Fortress Biotech, Inc. (NASDAQ:FBIO) has received an average recommendation of “Buy” from the seven research firms that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $10.80.A ...
5/8/2021 Abbott, NEOGEN Corporation and OraSure Technologies, Inc. Dominating in North America Saliva Test Devices in 2020 databridgemarketresearch.com ... Canada authorization received by the company has increased its sales and revenue in future.Abbott is the dominating player in North America saliva test devices saliva test devices market includes OraSure Technologies, Inc., Premier Biotech , Inc., Confirm Biosciences, GC America Inc., Thermo Fisher Scientific Inc., DNA Genotek Inc. (a subsidiary of OraSure Technologies, Inc.), BNTX Inc., Vitagene, Alfa Scientific Designs, Inc., NEOGEN Corporation, Oranoxis Inc., Oasis Diagnostics Corporation, Salimetrics, LLC ...
5/8/2021 Brickell Biotech (NASDAQ:BBI) Downgraded to “Sell” at Zacks Investment Research rivertonroll.com Brickell Biotech (NASDAQ:BBI) Downgraded to “Sell” at Zacks Investment Research Posted by Lars CharterZacks Investment Research downgraded shares of Brickell Biotech (NASDAQ:BBI) from a hold rating to a sell rating in a report released on Tuesday morning, Zacks.com reports.According to Zacks, “Brickell Biotech, Inc. is a clinical-stage pharmaceutical company. It is focused on developing prescription therapeutics for treatment of skin diseases. The company’s ...
5/8/2021 CD Bioparticles Announces Iron-based MOFs (Fe-MOF) to Support Research nationalnewsmagazine.com ... high quality materials are fine tuning MOFs for industrial applications, and CD Bioparticles can supply highly-porous, suitably robust, shaped MOFs that are tailored to researchers’ applications, such as membrane separation, sensors and biotech feasibility studies under real conditions. In this release, various products can be found at CD Bioparticles, such as F-free MIL-100 (Fe), MIL-88B-Fe, NH2-MIL-101 (Fe), NH2-MIL-88B (Fe), PCN ...